[1]严海忠,王 娟,卢兰芬,等.糖尿病患者感染产ESBLs肠杆菌科细菌的耐药性及危险因素分析[J].现代检验医学杂志,2018,33(05):82-86.[doi:10.3969/j.issn.1671-7414.2018.05.022]
　YAN Hai-zhong,WANG Juan,LU Lan-fen,et al.Analysis of the Drug Resistance and Risk Factors of ESBLs-Producing Enterobacteriaceae Infection in Diabetics[J].Journal of Modern Laboratory Medicine,2018,33(05):82-86.[doi:10.3969/j.issn.1671-7414.2018.05.022]
点击复制

糖尿病患者感染产ESBLs肠杆菌科细菌的耐药性及危险因素分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第33卷
期数:
2018年05期
页码:
82-86
栏目:
论著
出版日期:
2018-11-18

文章信息/Info

Title:
Analysis of the Drug Resistance and Risk Factors of ESBLs-Producing Enterobacteriaceae Infection in Diabetics
文章编号:
1671-7414(2018)05-082-05
作者:
严海忠; 王 娟; 卢兰芬; 冯雪琴
中山大学附属中山医院检验医学中心,广东中山 528403
Author(s):
YAN Hai-zhong; WANG Juan; LU Lan-fen; FEN Xue-qin
the Center for Medicine Laboratory, Sun Yat-sen Hospital Affiliated to Sun Yat-sen University,Guangdong Zhongshan528403,China
关键词:
糖尿病;  超广谱β-内酰胺酶;  耐药;  危险因素
分类号:
R587.1; R446.5
DOI:
10.3969/j.issn.1671-7414.2018.05.022
文献标志码:
A
摘要:
目的 了解中山市糖尿病患者感染产超广谱β-内酰胺酶(extended spectrum β-Lactamases,ESBLs)肠杆菌科细菌的耐药性及危险因素。方法 收集2014年1月～2016年6月中山大学附属中山医院120例确诊糖尿病并发感染产ESBLs肠杆菌科细菌患者的临床标本132例和临床资料。通过VTIEK 2 COMPCT全自动微生物鉴定系统进行菌种鉴定和药物敏感试验; 使用VITEK 2 COMPCT高级专家系统判定菌株的耐药表型和耐药模式,同时根据是否产ESBLs,把主要致病菌大肠埃希菌分为ESBLs-positive组和ESBLs-negative组,比较两组在耐药模式之间的区别。对患者的各项临床资料进行logistic回归分析糖尿病并发感染产ESBLs肠杆菌科细菌的危险因素。结果糖尿病患者感染产ESBLs肠杆菌科细菌主要是大肠埃希菌,其次是肺炎克雷伯菌,感染标本来源主要是中段尿。大肠埃希菌和肺炎克雷伯菌对厄他培南和亚胺培南敏感度为100%,对头孢替坦和哌拉西林/他唑巴坦的敏感度大于98%。大肠埃希菌ESBLs-positive组和ESBLs-negative组在获得性青霉素酶、β-内酰胺类抗生素野生型、其他超广谱β-内酰胺酶和CTX-M型ESBLs四种耐药模式之间差异均有统计学意义(χ2=17.34,19.23,33.90,42.75,均P<0.05)。经logistic回归分析,年龄、住院次数、性别、糖尿病病程、收缩压、糖化血红蛋白水平、抗生素使用情况、感染前的治疗情况、类固醇药物应用、外科手术、侵入性操作、并发症等均不是产ESBLs肠杆菌科细菌感染的危险因素。结论 大肠埃希菌和肺炎克雷伯菌是糖尿病患者感染产ESBLs肠杆菌科的主要致病菌,感染部分主要是泌尿系统。产ESBLs肠杆菌对厄他培南、亚胺培南、头孢替坦和哌拉西林/他唑巴坦敏感。大肠埃希菌ESBLs-positive组和ESBLs-negative组主要表现为四种耐药模式的差异。年龄、住院次数和性别等常见因素均不是糖尿病患者感染产ESBLs肠杆菌科细菌的危险因素。
Abstract:
Objective To study the drug resistance and riskfactors for ESBLs-producing Enterobacteriaceae infection in diabetics in Zhongshan.Methods 132 strains and clinical data were collected from January 2014 to June 2016 in 120 diabetes with Enterobacteriaceae bacteria infection in the Sun Yat-sen Hospital Affiliated to Sun Yat-sen University.VTIEK 2 COMPCT automatic microbial identification system was used to identify strains and test drug sensitivity.The resistance phenotype and resistancepattern of the strain were determined by VTIEK 2 COMPCT advanced expert system.According to whether ESBLs was produced,the main pathogenic bacteria of Escherichia coli was divided into the ESBLs-positive group and the ESBLs-negative group,then compared the differences between the two groups in drug resistance patterns.Logistic regression was performed to analyze the risk factors for ESBLs-producing Enterobacteriaceae infection in diabetics.ResultsThe main pathogenic bacteria of diabetes patients with ESBLs-producing infection was Escherichia coli,followed by Klebsiella pneumoniae.The main source of infection was middle-stage urine.Escherichia coli andKlebsiella pneumonia bacteria were sensitive to Ertapenem and Imipenem,thesusceptible rate to cefotetan and Piperacillin/Tazobactam was higher than 98%.Four modes of resistances(Acquired penicillinase,Wild-beta-lactam antibiotic,other ESBLs,ESBLs(CTX-M LIKE))had significant differences between the ESBLs-positive and ESBLs-negative groups(χ2=17.34,19.23,33.90,42.75,all P<0.05).Through logistic regression analysis,age,times of hospitalization,sex,diabetes duration,blood pressure,hemoglobin A1c levels,the usage of antibiotics,infection before the treatment and application of steroid andsurgery,invasive operation and complications were not the risk factors of ESBLsinfection.Conclusion Escherichia coli and Klebsiella pneumoniae were the main pathogenic bacterias of ESBLs-producing Enterobacteriaceae in diabetic patients.The infection was mainly in the urinary system.ESBLs-producing Enterobacteriaceae were sensitive to Ertapenem,Imipenem,Cefotetan and Piperacillin/Tazobactam.Four modes of resistances had significant differences between the ESBLs-positive and ESBLs-negative groups.Age,the times of hospitalization,gender and other common factors were not the risk factors of the infection of ESBLs-producing Enterobacteriaceae bacteria in diabetic patients.

参考文献/References:

[1] 侯清涛,李 芸,李舍予,等.全球糖尿病疾病负担现状[J].中国糖尿病杂志,2016,24(1):92-96.
Hou QT,Li Y,Li SY,et al.The global burden of diabetes mellitus[J].Chinese Journal of Diabetes,2016,24(1):92-96.
[2] 常 青.糖尿病感染患者的病原菌分布及耐药性分析[J].中国医药导刊,2013,15(7):1118-1120.
Chang Q.Analysis of distribution and drug resistance of common pathogens in diabetic infection patients[J].Chinese Journal of Medical Guide,2013,15(7):1118-1120.
[3] 金 晶,吴伟平,林菲菲,等.糖尿病患者感染病原菌分布与耐药性分析[J].中华医院感染学杂志,2015,25(14):3153-3155.
Jin J,Wu WP,Lin FF,et al.Distribution and drug resistance of pathogenic bacteria in patients with diabetes mellitus[J].Chinese Journal of Nosocomiology,2015,25(14):3153-3155.
[4] Andersen K,Kesper MS,Marschner JA,et al.Intestinal dysbiosis,barrierdysfunction,and bacterial translocation account for CKD-related systemic inflammation[J].Journal of the American Society of Nephrology Jasn,2017,28(1):76-83.
[5] Schneeberger C,Erwich JJHM,Vanden Heuvel ER,et al.Asymptomatic bacteriuria and urinary tract infection in pregnant women with and without diabetes:Cohort study[J].Eur J Obstet Gynecol Reprod Biolr,2018,222(42):176-181.
[6] Vinken JEM,Mol HE,Verheij TJM,et al.Antimicrobial resistance in womenwith urinary tract infection in primary care:No relation with type 2 diabetesmellitus[J].Prim Care Diabetes 2018,12(1):80-86.
[7] 徐学静,曹小利,张之烽,等.血培养大肠埃希菌的药物敏感性分析及ESBLs编码基因的流行性分析[J].现代检验医学杂志,2016,31(1):55-57.
Xu XJ,Cao XL,Zhang ZF,et al.Analysis on the antimicrobial susceptibilities and the prevalence of ESBLs encoding genes of Escherichia coli isolates colleted from blood[J].J Mod Lab Med,2016,31(1):55-57.
[8] Thaden JT,Fowler VG,Sexton DJ,et al.Increasing extended-spectrum β-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States[J].Infection Control & Hospital Epidemiology,2016,37(1):49-54.
[9] Al-Mayahie S,Al Kuriashy JJ.Distribution of ESBLs among Escherichiacoli isolates from outpatients with recurrent UTIs and their antimicrobial resistance[J].Infect Dev Ctries,2016,10(6):575-583.
[10] 谈 昀,丁晓勇,白 晓.产β-内酰胺酶大肠埃希菌的临床分布及耐药性分析[J].现代检验医学杂志,2015,30(2):74-76.
Tan Y,Ding XY,Bai X.Clinical distribution and drug resistance analysisof 1 587 Escherichia coli[J].J Mod Lab Med,2015,30(2):74-76.
[11] Al-Agamy MH,Aljallal A,Radwan HH,et al.Characterization of carbapenemases,ESBLs,and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals[J].J Infect Public Health,2017,11(1):64-68.
[12] Leistner R,Denkel LA,Gastmeier P,et al.Prevalence of MRSA and gram-negative bacteria with ESBLs and carbapenemases in patients from northern africaat a German hospital[J].Journal of Antimicrob Chemother 2015,70(11):3161-3164.
[13] 张海燕.老年糖尿病住院患者合并感染的特点及其危险因素分析[D].大连:大连医科大学,2016.
Zhang HY.Analysis of the characteristics and risk factors of combined infection in elderly patients with diabetes mellitus[D].Dalian:Dalian Medical University,2016.

相似文献/References:

[1]徐学静,曹小利,张之烽,等.血培养大肠埃希菌的药物敏感性分析及ESBLs编码基因的流行性分析[J].现代检验医学杂志,2016,31(01):55.[doi:10.3969/j.issn.1671-7414.2016.01.015]
　XU Xue-jing,CAO Xiao-li,ZHANG Zhi-feng,et al.Analysis on the Antimicrobial Susceptibilities and the Prevalenceof ESBLs Encoding Genes of Escherichia Coli Isolates Collected from Blood[J].Journal of Modern Laboratory Medicine,2016,31(05):55.[doi:10.3969/j.issn.1671-7414.2016.01.015]
[2]谭婷婷,程 莉,魏红霞,等.尿α1-酸性糖蛋白在早期糖尿病肾病诊断中的应用价值[J].现代检验医学杂志,2016,31(01):80.[doi:10.3969/j.issn.1671-7414.2016.01.023]
　TAN Ting-ting,CHENG Li,WEI Hong-xia,et al.Value of Urinary α1-Acid Glycoprotein in Early Diagnosis of Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2016,31(05):80.[doi:10.3969/j.issn.1671-7414.2016.01.023]
[3]翟海军,朱 晶.NSE在糖尿病周围神经病变中的应用价值[J].现代检验医学杂志,2015,30(04):161.[doi:10.3969/j.issn.1671-7414.2015.04.050]
　ZHAI Hai-jun,ZHU Jing.Application of NSE in Diabetic Peripheral Neuropathy[J].Journal of Modern Laboratory Medicine,2015,30(05):161.[doi:10.3969/j.issn.1671-7414.2015.04.050]
[4]谈 昀,丁晓勇,白 晓.产β-内酰胺酶大肠埃希菌的临床分布及耐药性分析[J].现代检验医学杂志,2015,30(02):74.[doi:10.3969/j.issn.1671-7414.2015.02.023]
　TAN Yun,DING Xiao-yong,BAI Xiao.Clinical Distribution and Drug-resistance Analysis of 1 587 Escherichia coli[J].Journal of Modern Laboratory Medicine,2015,30(05):74.[doi:10.3969/j.issn.1671-7414.2015.02.023]
[5]詹 颉,张 华,闫福堂,等.血清NGAL与Cr,BUN,RBP,Cys-C联合检测在糖尿病肾病早期诊断中的应用[J].现代检验医学杂志,2016,31(04):100.[doi:10.3969/j.issn.16717-414.2016.04.028]
　ZHAN Jie,ZHANG Hua,YAN Fu-tang,et al.Application of Combined Detection of Serum NGAL and Cr,BUN,RBP and Cys C in Early Diagnosis of Diabetic Nephropathy[J].Journal of Modern Laboratory Medicine,2016,31(05):100.[doi:10.3969/j.issn.16717-414.2016.04.028]
[6]王洋一,胡宏章.在不同性别及年龄间糖化血红蛋白水平差异分析[J].现代检验医学杂志,2017,32(02):123.[doi:10.3969/j.issn.1671-7414.2017.02.034]
　WANG Yang-yi,HU Hong-zhang.Differential Analysis of Glycosylated Hemoglobin in Different Sex and Age[J].Journal of Modern Laboratory Medicine,2017,32(05):123.[doi:10.3969/j.issn.1671-7414.2017.02.034]
[7]张求霞a,汪隆海a,昌国庆a,等.尿液6种蛋白与CysC水平检测对糖尿病肾病的诊断价值[J].现代检验医学杂志,2019,34(01):67.[doi:10.3969/j.issn.1671-7414.2019.01.017]
　ZHANG Qiu-xiaa,WANG Long-haia,CHANG Guo-qing a,et al.Clinical Value of Detection of 6 Proteins and Cystatin C in Urine for Early Diagnosis of Diabetic Kidney Disease[J].Journal of Modern Laboratory Medicine,2019,34(05):67.[doi:10.3969/j.issn.1671-7414.2019.01.017]
[8]廖衍强.糖尿病并发高血压患者血清Cys C 与P 物质水平之间的关系研究[J].现代检验医学杂志,2020,35(02):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
　LIAO Yan-qiang.Relationship between Serum Cys C and Substance P Levels in Patientswith Diabetes Mellitus Complicated with Hypertension[J].Journal of Modern Laboratory Medicine,2020,35(05):65.[doi:10.3969/j.issn.1671-7414.2020.02.019]
[9]张海霞a,郭 杰a,袁 宁a,等.老年健康体检人群外周血红细胞分布宽度与糖化血红蛋白A1c 的相关性研究[J].现代检验医学杂志,2020,35(04):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
　ZHANG Hai-xia a,GUO Jiea,YUAN Ninga,et al.Association of Peripheral Blood Red Blood Cell Distribution Width with Glycated Hemoglobin A1c in the Healthy Elderly Population for Check-ups[J].Journal of Modern Laboratory Medicine,2020,35(05):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
[10]赵淑珍,郑锦仁,陈媛,等.血清糖化清蛋白检测方法学评价、临床性能验证及其在糖尿病监测的应用研究[J].现代检验医学杂志,2020,35(05):77.[doi:10.3969/j.issn.1671-7414.2020.05.020]
　ZHAO Shu-zhen,ZHENG Jin-ren,CHEN Yuan,et al.Application of Glycated Albumin in Diabetes Monitoring Indicators[J].Journal of Modern Laboratory Medicine,2020,35(05):77.[doi:10.3969/j.issn.1671-7414.2020.05.020]

备注/Memo

备注/Memo:
作者简介:严海忠(1985-),男,本科,主管技师,主要从事血液及泌尿系统感染研究,E-mail:yanhaizhong.love@163.com。
更新日期/Last Update: 2018-09-30